You have 9 free searches left this month | for more free features.

Condition

AML (1)

Advanced Solid Tumors (1)

Brain Metastases (1)

CMML (1)

MDS (1)

Malignant Melanoma (1)

Overall Status

Terminated (2)

Unknown status (1)

Sign in for free

Phase

phase 1 (2)

phase 1/phase 2 (1)

Sponsor

Spirita Oncology, LLC (2)

Eisai Inc. (1)

Collaborator

University of Arizona (1)

Intervention

e6201 (3)

e6201 plus dabrafenib (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

e6201

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Malignant Melanoma, Brain Metastases Trial in Tucson (E6201, E6201 plus dabrafenib)

Terminated

Has Results

Malignant Melanoma
Brain Metastases

E6201
E6201 plus dabrafenib

Tucson, Arizona

University of Arizona Cancer Center

Mar 5, 2022

AML, MDS, CMML Trial in United States (E6201)

Terminated

Has Results

AML
+2 more

E6201

Denver, Colorado
+3 more

Mar 7, 2019

Advanced Solid Tumors Trial in United States (E6201)

Unknown status

Advanced Solid Tumors

E6201

Scottsdale, Arizona
+11 more

Sep 3, 2014